In a groundbreaking experiment conducted by scientists at The College of the University Of Texas at Houston, HIV preventive programs would be paired with exposure to gender-affirming hormone treatment and awareness campaigns guidance to seek to minimize the growing number of trans females who are HIV positive (UTHeath).
Change The Broken Healthcare System To Lower HIV Rates Among Trans Women
“It’s critical how we address the housing requirements of transsexual people in Houston,” stated Jordan E. Lake, MD, MSc, the lead researcher for the UTHealth page as well as an assistant dean of communicable diseases at McGovern Clinical College at UTHealth. “A combined strategy that includes HIV prevention programs and hormone treatment, as well as awareness campaigns management, may have a huge effect mostly on HIV outbreak in this community.”
In the United States, there are approximately 1.1 million trans people, with Fourteen percent of trans females diagnosed with HIV. According to the findings of a 2011 study of trans people in the United States, 28 percent of participants had put off obtaining medical treatment because of past prejudice.
Gender-affirming health treatment and HIV prevention programs necessitate a unique strategy. The ability to vital and even existence treatment can be jeopardized when obstacles to care remain, and sufferers could be at a greater threat of HIV infection than when these facilities were widely accessible in a sexuality set. Access to female treatment has also been linked to better health results, according to studies.
The study group will assess the effects of a combined approach of sexual identity healthcare and HIV preventive care, such as post prophylaxis (PrEP) and diagnosis and screening for certain sexually transmitted diseases in bisexual females who’ve been HIV null. Patients will be enrolled at Harris Health Program’s Thomas Street Local Clinic.
“This research provides a path for several trans individuals whom experience stigma, prejudice, social ostracization, and isolation to obtain resources housing, and HIV preventive facilities amongst many tools,” Byancha Lawson, a peer medical navigator for the study, stated. “Higher levels, of imprisonment mental illnesses, and abuse are variables that impact trans individuals’ safety and well-being, putting them at significant threat for Hcv infection,” Lawson added.
Respondents should provide an undisclosed HIV condition or be HIV null to be eligible for the 18-month study. Sufferers will be randomized into 2 categories, rapid or deferred treatment after they have been screened for HIV and verified to be null.
For the duration of the study at Thomas Street Healthcare Facility, the rapid treatment community will be given PrEP and female hormone treatment in conjunction with mutual medical guidance. People from the same group as the target group serve as peer care explorers. They are instructed to assist patients in navigating the health process and removing obstacles to treatment.
Many in the delayed treatment category will obtain HIV preventive treatment for the duration of the research but will be directed to certain agencies for female treatment and nursing practice for the first 6 months. They would obtain the very same mix package as the rapid treatment community for the duration of the trial after these 6 months.